Perioperative medicine & outcomes

Transcutaneous Electrical Acupoint Stimulation vs Metoclopramide for Moderate to Severe Postoperative Nausea and Vomiting: A Randomized Clinical Trial

JAMA SurgPublished Randomised controlled trial

Authors' conclusion

In this study, wearable TEAS significantly outperformed metoclopramide for moderate to severe PONV, representing an effective nonpharmacological alternative that enhances postanesthesia recovery.

Study context

Population
Female patients aged 25 to 55 years scheduled for thyroidectomy or anterior cervical surgery under GA who developed moderate to severe postoperative nausea and vomiting (PONV) (NRS ≥4), 4 hospitals in Shanghai and Tianjin, Chinaall completed
Participants
232 patients
Comparison
Transcutaneous electrical acupoint stimulation (TEAS) vs Control
  • TEASn = 116
  • Controln = 116reference
Primary endpoint
PONV remission rate following initial intervention (significant symptom relief, NRS ≤3)
Follow-up
2 hours
Methodological detailsdouble-dummy, patient-blinded and observer-blinded, parallel-group, active-controlled, multicentre (4 hospitals), Non-responders (NRS ≥4) at 2 hours rerandomised to cross-intervention
  • Double-dummy
  • Patient-blinded and observer-blinded
  • Parallel-group
  • Active-controlled
  • Multicentre (4 hospitals)
  • Non-responders (NRS ≥4) at 2 hours rerandomised to cross-intervention

Primary result

As reported in the abstract

2-hour PONV remission rate

P < 0.001

Further findings

OutcomeTEASControlP value
24-hour relapse rate12.2% (95% CI 7.0%–20.6%)56.3% (95% CI 44.1%–67.7%)P < 0.001

Safety

No adverse events reported

Original publication

Transcutaneous Electrical Acupoint Stimulation vs Metoclopramide for Moderate to Severe Postoperative Nausea and Vomiting: A Randomized Clinical Trial. JAMA Surg. Published 1 March 2026. doi:10.1001/jamasurg.2025.6394

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.